Pilocytic astrocytoma
Clinical trials for Pilocytic astrocytoma explained in plain language.
Never miss a new study
Get alerted when new Pilocytic astrocytoma trials appear
Sign up with your email to follow new studies for Pilocytic astrocytoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New proton therapy aims to shield memory in kids with brain cancer
Disease control OngoingThis study tests a new way to give proton radiation to children with low-grade glioma, a common brain tumor. The goal is to avoid the hippocampus, a brain area key for memory, to reduce long-term memory loss. About 74 children will receive this targeted radiation, and researchers…
Matched conditions: PILOCYTIC ASTROCYTOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Kids' brain tumor drugs tested for Long-Term safety
Disease control OngoingThis study follows 165 children who previously took dabrafenib and/or trametinib for certain brain tumors. Researchers want to see if these drugs are safe over the long term and how they affect growth. The children continue their treatment and are monitored for side effects and d…
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a parasite drug fight childhood brain tumors?
Disease control OngoingThis trial is testing whether mebendazole, a drug commonly used to treat intestinal parasites, can help children with brain tumors called gliomas. The study combines mebendazole with standard chemotherapy drugs to see if it is safe and effective. It includes children and young ad…
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase 1/2 • Sponsor: Julie Krystal • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for kids with tough brain tumors: targeted drug shows promise
Disease control OngoingThis study tests a drug called selumetinib in children and young adults with low grade glioma that has come back or not responded to other treatments. The drug works by blocking certain enzymes that help tumor cells grow. The goal is to find the best dose and see if it can shrink…
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC